218 related articles for article (PubMed ID: 27845189)
1. Genome analyses identify the genetic modification of lung cancer subtypes.
Zhang Y; Wang DC; Shi L; Zhu B; Min Z; Jin J
Semin Cancer Biol; 2017 Feb; 42():20-30. PubMed ID: 27845189
[TBL] [Abstract][Full Text] [Related]
2. A global view of regulatory networks in lung cancer: An approach to understand homogeneity and heterogeneity.
Lu J; Wang W; Xu M; Li Y; Chen C; Wang X
Semin Cancer Biol; 2017 Feb; 42():31-38. PubMed ID: 27894849
[TBL] [Abstract][Full Text] [Related]
3. Global analysis of chromosome 1 genes among patients with lung adenocarcinoma, squamous carcinoma, large-cell carcinoma, small-cell carcinoma, or non-cancer.
Zhang Y; Wang H; Wang J; Bao L; Wang L; Huo J; Wang X
Cancer Metastasis Rev; 2015 Jun; 34(2):249-64. PubMed ID: 25937073
[TBL] [Abstract][Full Text] [Related]
4. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
[TBL] [Abstract][Full Text] [Related]
5. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
Fathi Z; Mousavi SAJ; Roudi R; Ghazi F
PLoS One; 2018; 13(7):e0200633. PubMed ID: 30048458
[TBL] [Abstract][Full Text] [Related]
6. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
[TBL] [Abstract][Full Text] [Related]
7. The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers.
Oh JJ; Koegel AK; Phan DT; Razfar A; Slamon DJ
Lung Cancer; 2007 Oct; 58(1):7-14. PubMed ID: 17606309
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
[TBL] [Abstract][Full Text] [Related]
9. Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development.
Lockwood WW; Wilson IM; Coe BP; Chari R; Pikor LA; Thu KL; Solis LM; Nunez MI; Behrens C; Yee J; English J; Murray N; Tsao MS; Minna JD; Gazdar AF; Wistuba II; MacAulay CE; Lam S; Lam WL
PLoS One; 2012; 7(5):e37775. PubMed ID: 22629454
[TBL] [Abstract][Full Text] [Related]
10. Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.
Hlaing AM; Furusato B; Udo E; Kitamura Y; Souda M; Masutani M; Fukuoka J
Biochem Biophys Res Commun; 2018 Sep; 503(4):2764-2769. PubMed ID: 30100056
[TBL] [Abstract][Full Text] [Related]
11. In silico comparative genomic analysis of two non-small cell lung cancer subtypes and their potentials for cancer classification.
Li J; Li D; Wei X; Su Y
Cancer Genomics Proteomics; 2014; 11(6):303-10. PubMed ID: 25422361
[TBL] [Abstract][Full Text] [Related]
12. Common and contrasting genomic profiles among the major human lung cancer subtypes.
Tonon G; Brennan C; Protopopov A; Maulik G; Feng B; Zhang Y; Khatry DB; You MJ; Aguirre AJ; Martin ES; Yang Z; Ji H; Chin L; Wong KK; Depinho RA
Cold Spring Harb Symp Quant Biol; 2005; 70():11-24. PubMed ID: 16869734
[TBL] [Abstract][Full Text] [Related]
13. Classification of non-small cell lung cancer based on copy number alterations.
Li BQ; You J; Huang T; Cai YD
PLoS One; 2014; 9(2):e88300. PubMed ID: 24505469
[TBL] [Abstract][Full Text] [Related]
14. Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer.
Bao L; Zhang Y; Wang J; Wang H; Dong N; Su X; Xu M; Wang X
Cell Biol Toxicol; 2016 Oct; 32(5):419-35. PubMed ID: 27301951
[TBL] [Abstract][Full Text] [Related]
15. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
[TBL] [Abstract][Full Text] [Related]
16. Protein expression profiles of non-small cell lung carcinomas: correlation with histological subtype.
Volm M; Koomägi R; Efferth T; Mattern J
Anticancer Res; 2002; 22(4):2321-4. PubMed ID: 12174921
[TBL] [Abstract][Full Text] [Related]
17. The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies.
Varker KA; Phelps SH; King MM; Williams CL
Int J Oncol; 2003 Mar; 22(3):671-81. PubMed ID: 12579323
[TBL] [Abstract][Full Text] [Related]
18. Integrated classification of lung tumors and cell lines by expression profiling.
Virtanen C; Ishikawa Y; Honjoh D; Kimura M; Shimane M; Miyoshi T; Nomura H; Jones MH
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12357-62. PubMed ID: 12218176
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical profiling of ALK fusion gene-positive adenocarcinomas of the lung.
Sakai Y; Nakai T; Ohbayashi C; Imagawa N; Yanagita E; Satake R; Nitta A; Kajimoto K; Sakuma T; Itoh T
Int J Surg Pathol; 2013 Oct; 21(5):476-82. PubMed ID: 23794492
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of tumor suppressor gene deletion between squamous cell carcinoma and adenocarcinoma lung cancer in Chinese].
An Q; Liu Y; Huang J
Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):470-2. PubMed ID: 11859712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
